This week, I have an announcement to make. Find out more at https://LifeScienceTodayPodcast.com About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the...
Vaccine hesitancy, the most expensive gene therapy in the world, a $178M series D, and a $1.3B buyout Find out more at https://LifeScienceTodayPodcast.com Story References Sanofi/Takeda UniQure & CSL Fog Pharma Merck + Imago About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equit...
A $145M opioid acquisition, biobucks for the holidays, a series A, and diabetes approvals Find out more at https://LifeScienceTodayPodcast.com Story References Indivior + Opiant Regeneron + CytomX Rezo Provention About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the st...
More CRISPR data, oncology wins, and a new player in ophthalmology Find out more at https://LifeScienceTodayPodcast.com Story References Intellia Regeneron Viatris + Oyster Point About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPO...
Billion-dollar acquisitions, troubled waters for some biotech’s, and a prosperous outlook for others Find out more at https://LifeScienceTodayPodcast.com Story References Sumitovant + Myovant Thermo Fisher + Binding Site Group Astellas & Taysha Agios Vaxctye About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of ...
Some statistically significant guidance, seed to acquisition, some biobucks, and the CART of the future. Find out more at https://LifeScienceTodayPodcast.com Story References FDA AbbVie + DJS Roche + Hookipa Kyverna About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how t...
One biotech is on a roll, another is moving quickly, Amazon money for cancer, and some clinical development news Find out more at https://LifeScienceTodayPodcast.com Story References DICE Odyssey Fred Hutch Merck (MSD), Merck Story 2 About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private...
Major Alzheimer’s news, an ALS approval, and expanded therapies for skin conditions Find out more at https://LifeScienceTodayPodcast.com Story References Eisai + Biogen Amylyx Sanofi + Regeneron About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market respond...
A $900 raise, gene therapy news, a quick IPO, and merge three for $100M Find out more at https://LifeScienceTodayPodcast.com Story References Alnylam, Link 2, Link 3 Intellia Therapeutics Third Harmonic Bio Galvanize Therapeutics About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equit...
A critical aesthetics approval, site network buy-up, a very normal oncology biotech, and a busy week for one company. Find out more at https://LifeScienceTodayPodcast.com Story References Revance Velocity + MedPharmics Arsenal SpringWorks Link 1, Link 2, Link 3 About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the move...
A $1.1B acquisition, two FDA approvals, and grants for mRNA vaccines. Find out more at https://LifeScienceTodayPodcast.com Story References Novo + Forma Sanofi Boehringer Ingelheim Arcturus About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market respo...
Ophthalmology acquisitions, following the pharma trends, and a move in healthcare that is not technology related. Find out more at https://LifeScienceTodayPodcast.com Story References Alcon + Aerie Novartis + Sandoz Labcorp + RWJBH About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and priva...
Gene therapy approval, opioid costs continue, a $650M deal, and a $3.5B RNA partnership. Find out more at https://LifeScienceTodayPodcast.com Story References Bluebird Endo & Pharmacies Genentech + Jemincare Merck + Orna About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, a...
Spending that COVID money, brain money, Irish money, and another oncology approval. Find out more at https://LifeScienceTodayPodcast.com Story References Pfizer Cerevel Abbott AstraZeneca + Daiichi Sankyo About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock mar...
This week, we take a break from stories of raising capital, mergers, and FDA approvals to look at the dark side of our industry. What happens when companies fail, people lie, and good drugs make bad lives? Find out more at https://LifeScienceTodayPodcast.com Story References Zymergen + Ginkgo Cassava Teva About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical...
There’s a SPAC, expanded FDA approval, more of the common, and two Bs, two As Find out more at https://LifeScienceTodayPodcast.com Story References ZyVersa Incyte Revolution Frontera CAMP4 ForSight Auron About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock marke...
Cell therapy acquisition, royalties sold, biobucks-like deal, successful raise, and Chinese Venture Capital Find out more at https://LifeScienceTodayPodcast.com Story References Vertex + ViaCyte Theravance Biopharma Merck + Orion Pliant Therapeutics Qiming About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of vent...
FEED DROP - Clinical Research Evolved Noah and John talk with Dan Agroskin, a managing director at a leading private equity firm with a focus on the clinical research industry. We discuss how investments shape industries, what entrepreneurs should think about private equity, and the forces that drive exceptional business growth. Find Out More Dan Agroskin Clinical Research Evolved Noah Goodson, PhD John Reites Kyle Ricketts About the Show Life Science Today is your source for stories, ...
Double acquisition, private money, affordable deals, and a surprising $70M launch Find out more at https://LifeScienceTodayPodcast.com Story References Galapagos + CellPoint + AboundBio Radius Ipsen + Epizyme DEM Bio About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how t...
Crohn’s approval, new VC round, direct offerings, and potential asset sales. Find out more at https://LifeScienceTodayPodcast.com Story References AbbVie Third Rock Scholar Rock Kyowa Kirin About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market respo...